Ulcerative Colitis Clinical Study
Interested in learning more about this clinical trial? Schedule a time to connect with a member of our research team and get your questions answered. Our online scheduling platform makes it simple to choose a time that works for you and learn more about what participation may involve. Click here to get started!
Diagnosed with Ulcerative Colitis and Considering Non-Drug Treatment?
MNGI Digestive Health and Minnesota Urology are recruiting patients diagnosed with ulcerative colitis (UC) for a new clinical study that is evaluating how effective sacral nerve modulation is for the treatment of UC.
Sacral nerve modulation is FDA-approved to treat overactive bladder and fecal incontinence. Patients who qualify for the study will have a minimally invasive procedure to have a small medical device implanted. Patients will be closely monitored to see how well the device helps manage their UC symptoms.
Subjects can receive study stipends to help compensate them for their time and travel to study visit appointments that they complete.